Expression of HER-2/neu marker in gastric adenocarcinoma is different in various part of the world (15) and findings of the present study show that expression of HER-2/neu marker has been shown in 6 cases (10%) of 60 samples. This evidence concerns the gene ERBB2 and gastric adenocarcinoma.